Related Experiment Video
Updated: Oct 2, 2026

Visualization of Bacterial Toxin Induced Responses Using Live Cell Fluorescence Microscopy
Published on: October 1, 2012
Extracellular Bad fused to toxin transport domains induces apoptosis
Makoto Ichinose1, Xiu-Huai Liu, Naoshi Hagihara
1Biochemistry Section, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA.
Abstract:
Bad, a proapoptotic member of the Bcl-2 family, is inactivated by phosphorylation, and this loss of activity may contribute to the malignancy of certain types of tumors such as glioblastoma and prostate cancer. To determine whether extracellular Bad can be delivered into cells via cell surface receptor binding and induce apoptosis, we genetically fused the mouse Bad gene to the gene for the translocation and receptor-binding domains of diphtheria toxin (DTTR). The purified Bad (wild-type)-DTTR protein showed cytotoxicity to human glioma cells in a dose-dependent manner. Bad phosphorylation sites at codons 112 and 136 were mutated from serine to alanine to prevent Bad inactivation by kinases and to increase the toxicity of Bad. The Bad (S112A S136A)-DTTR protein was at least 5 times more toxic than Bad (wild-type)-DTTR with an IC(50) of 5 x 10(-8) M. The Bad (S112A S136A)-DTTR protein altered the subcellular distribution of Bcl-X(L), indicating that it enters the cell cytoplasm and binds Bcl-X(L). Bad (S112D S136A)-DTTR, mutated to mimic phosphorylation of Bad, showed lower toxicity than either Bad (wild-type)-DTTR or Bad (S112A S136A)-DTTR, additionally indicating that Bad-DTTR must bind Bcl-X(L) to stimulate apoptosis. We conclude that extracellular Bad can be delivered into cells via the transport domain of a bacterial toxin and may be used to induce apoptosis.
Insights
Extracellular Bad protein, fused to diphtheria toxin, can enter cancer cells to induce apoptosis. Mutating Bad to prevent inactivation significantly increased its cancer-killing potency.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Bad is a proapoptotic protein inactivated by phosphorylation.
- This inactivation contributes to malignancies like glioblastoma and prostate cancer.
Purpose of the Study:
- To investigate if extracellular Bad can be delivered into cells to induce apoptosis.
- To develop a novel cancer therapy by targeting Bad delivery.
Main Methods:
- Genetically fused mouse Bad gene to diphtheria toxin translocation and receptor-binding domains (DTTR).
- Created mutated Bad proteins (S112A S136A and S112D S136A) to alter phosphorylation and activity.
- Assessed cytotoxicity and subcellular distribution of Bad-DTTR fusion proteins in human glioma cells.
Main Results:
- Bad-DTTR fusion protein demonstrated dose-dependent cytotoxicity to glioma cells.
- Mutating Bad phosphorylation sites (S112A S136A) increased toxicity by over 5-fold.
- The mutated Bad-DTTR entered cells, altered Bcl-X(L) distribution, and induced apoptosis.
Conclusions:
- Extracellular Bad can be effectively delivered into cells using a bacterial toxin's transport domain.
- Engineered Bad-DTTR fusion proteins show potential for inducing apoptosis in cancer cells.
- Targeted delivery of apoptosis-inducing proteins offers a promising strategy for cancer treatment.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Bacterial Toxins
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Apoptosis
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...

